Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus
about
Immune-mediated Liver Injury in Hepatitis B Virus InfectionKupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitisPlatelets: No longer bystanders in liver diseasePlatelets in inflammation and atherogenesisPlatelet adhesion under flow.Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.Effector CD8 T cell trafficking within the liverHepatic effector CD8(+) T-cell dynamics.Chronic hepatitis B: role of anti-platelet therapy in inflammation control.Spatiotemporal dynamics of effector CD8+ T cell responses within the liver.Mouse Models of Hepatitis B Virus PathogenesisEmerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma.Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection.Intravital Microscopy Analysis of Hepatic T Cell Dynamics.On the role of platelets in the pathogenesis of viral hepatitis.Nonalcoholic fatty liver disease and hepatocellular carcinoma
P2860
Q26786772-7A2DDC7B-69F9-4639-A9A0-9A776FF4C6CFQ27349825-A1ED3974-4C48-4AA3-9D0F-780AE505F3C8Q28071893-A4180BA8-5AA6-4DB2-8D4A-DFA113883103Q28085020-D91389B3-61F9-40B6-8B41-03EC07AD3221Q34673739-EDC458B7-1B5E-4FF3-A80B-3D4C5A355F4EQ36167647-B8E95026-7CCC-44AA-B0E8-3094C3FDA13DQ36625986-9FDE788B-B299-4DEB-A92F-C5D49E3EB356Q38252987-035919DB-99B2-4134-802E-5F308F8E1DE9Q38314202-D001AD1B-605A-4907-9E97-F7E5FECDDF39Q38549814-E8D57C3F-13B7-455B-BB30-241B1AA35C3DQ38570421-8CA5838D-4258-4BC8-AE27-B091B60E844FQ38923529-95B4FD07-4F4A-43FB-BBC6-A6DEF52C30B4Q39473320-CFEE38C8-035E-476F-A84C-9ECD8D3BC27CQ40481895-9E414F35-7A34-4879-AC6D-1582CD91E487Q43072421-3E97136D-C5A6-4EF4-AC01-C1E2B3B8E528Q57095486-7F602F5E-0F47-4A90-B583-8EDF62252BF0
P2860
Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antiplatelet drug therapy mode ...... plication-deficient adenovirus
@ast
Antiplatelet drug therapy mode ...... plication-deficient adenovirus
@en
Antiplatelet drug therapy mode ...... plication-deficient adenovirus
@nl
type
label
Antiplatelet drug therapy mode ...... plication-deficient adenovirus
@ast
Antiplatelet drug therapy mode ...... plication-deficient adenovirus
@en
Antiplatelet drug therapy mode ...... plication-deficient adenovirus
@nl
prefLabel
Antiplatelet drug therapy mode ...... plication-deficient adenovirus
@ast
Antiplatelet drug therapy mode ...... plication-deficient adenovirus
@en
Antiplatelet drug therapy mode ...... plication-deficient adenovirus
@nl
P2860
P50
P356
P1476
Antiplatelet drug therapy mode ...... plication-deficient adenovirus
@en
P2093
Iñigo Narvaiza
Zaverio M Ruggeri
P2860
P304
P356
10.1128/CVI.00298-07
P407
P577
2007-11-01T00:00:00Z